GLP1R and Alzheimer disease: Some scholars’ research shows that Liraglutide can reduce the occurrence of neuroinflammation to a certain extent while reducing Aβ plaques, and the above two are important causes of Alzheimer’s disease (AD), so GLP-1 RAs have great potential in the treatment of AD.275 Because Liraglutide has certain anti-inflammatory effect, can reduce the occurrence of neuroinflammation, some scholars believe that it will also play an irreplaceable role in the treatment of Parkinson’s disease.